GMED - Globus Medical, Inc.
| Previous close | 51.66 |
| Open | 51.35 |
| Bid | 0.00 x 0 |
| Ask | 53.24 x 100 |
| Day's range | 50.47 - 52.10 |
| 52-week range | 27.79 - 52.56 |
| Volume | 682,582 |
| Avg. volume | 626,650 |
| Market cap | 5.03B |
| Beta | 1.11 |
| PE ratio (TTM) | 47.31 |
| EPS (TTM) | 1.10 |
| Earnings date | 2 May 2018 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 52.89 |
- Zacks•2 months ago
Opko Health (OPK) in Focus: Stock Moves 6% Higher
Shares of Opko Health (OPK) rose nearly 6% on Friday.
- Motley Fool•2 months ago
Globus Medical Inc. 4th Quarter: The Rise of the Robot
The musculoskeletal-implant maker gets a boost from the launch of its Excelsius GPS robotic surgical system.
- Associated Press•2 months ago
Globus Medical tops Street 4Q forecasts
On a per-share basis, the Audubon, Pennsylvania-based company said it had net income of 25 cents. Earnings, adjusted for pretax expenses and non-recurring costs, came to 38 cents per share. The results ...
Market Realist•3 months agoA Deep Look at Globus Medical’s Financial Performance
Here's What's in Store for Globus Medical in 2018
Market Realist•3 months agoA Look at Globus Medical’s Segmental Performance
Globus Medical (GMED) classifies its products into innovative fusion products and disruptive technology products. Sales of innovative fusion products rose to $80.2 million in 3Q17 compared to $68.4 million in 3Q16. The increase was attributable to the increase from Alphatec’s international sales.
Market Realist•3 months agoTaking Stock of Globus Medical’s Recent Acquisitions
Globus Medical (GMED) recently launched a robotic surgical navigation device. Since its inception in 2003, Globus Medical has launched more than 180 products. Globus Medical acquired KB Medical, a Switzerland-based robotic developer, in June 2017.
Market Realist•3 months agoAnalyst Ratings for Globus Medical and Its Peers in February
Globus Medical (GMED) is a medical device company with a focus on designing, developing, and commercializing musculoskeletal solutions. Globus Medical’s sales force is comprised of direct sales representatives and distributor sales representatives employed by exclusive independent distributors. Of the 13 analysts covering Globus Medical in February 2018, seven of them have given the stock a “buy” or higher rating.
Market Realist•3 months agoBehind MiMedx Group’s Recent Financial Performance
Why Investors Are Eyeing MiMedx Group Today
- Market Realist•3 months ago
Why the Physician Office Pain Management Market Matters to MiMedx
Why Investors Are Eyeing MiMedx Group Today
Market Realist•3 months agoWhich Markets Is MiMedx Group Actually Targeting?
Why Investors Are Eyeing MiMedx Group Today
- Market Realist•3 months ago
Understanding MiMedx Group’s Zealous Focus on Sales
Why Investors Are Eyeing MiMedx Group Today
Market Realist•3 months agoMiMedx Group on the Street: Analyst Recommendations in January
MiMedx Group (MDXG) operates in the regenerative biomaterials segment. MiMedx is a leading global supplier of amniotic tissue products and has supplied over a million allografts in wound care, burns, surgery, orthopedics, spine, sports medicine, ophthalmology, and dentistry. Of the four analysts covering MiMedx Group in January 2018, three have given the stock a “buy” rating, and one analyst has given it a “strong buy” rating.
- Motley Fool•4 months ago
Why Globus Medical Should Be on Your Watch List
GMED has revamped some of their biggest issues, and could be on track for some significant long-term growth.
- Motley Fool•5 months ago
Mazor Robotics Might Need to Worry About This Potential Rival the Most (Hint: It's Not Intuitive Surgical)
A new spine surgery robot has arrived on the scene to challenge Mazor's current dominance.
- Investor's Business Daily•5 months ago
Stocks Showing Market Leadership: Globus Medical Earns 91 RS Rating
Globus Medical shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.
- Zacks•5 months ago
Globus Medical (GMED) Looks Good: Stock Adds 7.5% in Session
Globus Medical (GMED) saw its shares rise nearly 8% on the day after the company reported year-over-year growth in third-quarter earnings and revenues.
- Investor's Business Daily•5 months ago
Globus Medical Reaches 80-Plus Relative Strength Rating Benchmark
Globus Medical sees its Relative Strength Rating move into the 80-plus level.
- Zacks•6 months ago
Globus Medical (GMED) Q3 Earnings In Line, View Reiterated
Globus Medical (GMED) reports in-line third-quarter numbers on the back of higher revenues from core international business.
- Motley Fool•6 months ago
Globus Medical Inc. Posts Solid 3rd-Quarter Results With Robots in Its Future
The musculoskeletal-implant maker eyes its new Excelsius GPS robotic surgical system for future growth.
- Associated Press•6 months ago
Globus Medical meets 3Q profit forecasts
On a per-share basis, the Audubon, Pennsylvania-based company said it had profit of 26 cents. Earnings, adjusted for one-time gains and costs, came to 30 cents per share. The results met Wall Street expectations. ...
